Cannabis Law Report

FEBRUARY 4, 2019

Leaf Data Systems Update. Please contact your WSLCB Enforcement Officer if you have any questions about implementation and enforcement of this important public safety rule. Leaf Data Systems Update. The next software release for Leaf Data Systems is coming soon! Here’s the Table of Contents. Board Approves Jan.

Topical 65

Topical Packaging Retail Legislation 65

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 64

Safety Food CBD Oil 64

Canna Law Blog

DECEMBER 16, 2021

Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. Expansive List of Qualifying Medical Conditions. Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD.

Legislation 96

Legislation Treatment Therapy Conditions 96

Canna Law Blog

APRIL 13, 2019

For a complete list of questions and topics identified by the FDA, see here. The warning letters were released just a few days following Gottlieb’s testimony to a Senate subcommittee, in which he announced that his agency would use enforcement discretion against CBD product manufacturers who are making “over-the-line claims.”.

CBD 90

CBD Safety Topical Food 90

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

SEPTEMBER 20, 2021

The products leverage pharmaceutical technology to maximize performance and safety. Additional CB4 products from the Opticann suite of branded products will be launched in the upcoming weeks, including CB4 Derma skin cream and CB4 Clear face gel skincare products uniquely backed by product specific clinical trial data.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5. Easy access. What’s in your CBD?

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

SEPTEMBER 29, 2021

With patient safety at the center of its mission, TCI was created to educate healthcare professionals on the risks and benefits of medical cannabis, now legal in the state of New York and beyond.

Cannabinoids 52

Cannabinoids Education Patients Safety 52

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Cannigma

AUGUST 24, 2021

The Jointly database includes a very comprehensive assortment of flower stains, edibles, concentrates, tinctures, and topicals, and vows that “if it’s legal, we include it on our platform for the benefit of our community.”. The feedback is gathered and used to provide tailor made recommendations for products and doses. Learn More.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

Veriheal

AUGUST 3, 2021

Mainly, the measure protects patient safety and amplifies product quality requirements, all the while entrusting the state’s Medical Marijuana Advisory Board to consider broadening the program’s list of qualifying medical conditions. Yeast and mold are two examples of contaminants that are commonly found in cannabis products. .

Legislation 98

Legislation Patients Supply Chain Dispensary 98

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In

THC 52

THC CBD Media Food 52

Cannabis Law Report

JUNE 1, 2021

.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Data 95

Data Vaping Supply Chain Business 95

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., CBD is marketed in a variety of product types, such as oil drops, capsules, syrups, teas and topical lotions and creams.

CBD 40

CBD Research and Development Safety Therapy 40

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

The Cannigma

MAY 16, 2021

This data is particularly important for drivers, would-be drivers, policy makers, and anyone who is involved in carrying out or supervising safety sensitive tasks. Determining intoxication and impairment with cannabis is notoriously difficult and is nearly impossible to peg it to a per se limit of THC or its metabolites in the blood.

THC 145

THC Vaping Edibles CBD 145

Cannabis Law Report

AUGUST 27, 2021

Closing of the Private Placement is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including approval of the Toronto Stock Exchange. Each whole Warrant will entitle the holder to acquire one additional Common Share at a price of USD$0.50 HempFusion Wellness Inc.

Research and Development 105

Research and Development Events Hemp Food 105

Veriheal

JANUARY 5, 2022

Despite the restrictions on research as a result of the Schedule I classification of cannabis, researchers have made many remarkable strides in proving the efficacy and safety of cannabis on the aforementioned conditions. . While Biden is receiving a lot of heat as a result of his inaction, many feel it is deserved.

Legislation 52

Legislation Cannabis Therapy Access 52

CannaMD

DECEMBER 9, 2020

Little time will be devoted to opening sections which cover well-documented topics such as historic and current cannabis use, definitions, formulations, pharmacokinetics, pharmacodynamics, and policies on use. The authors also caution against the consumption of certain over-the-counter topical CBD products which do not fall under the U.S.

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

MAY 29, 2022

Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. The complex regulatory challenges around researching controlled substances have been a hot topic in recent years because of interest around medical marijuana. Approval Pathways.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 59

Marijuana Therapy Data THC 59

Cannabis Law Report

OCTOBER 29, 2021

The primary endpoint of this Phase 1 trial was safety and tolerability. We expect to report this data as it becomes available and after submission to the FDA. in thousands, except share data). . . . During the six months ended September 30, 2021, the Company raised approximately $4.1 < Financial Tables to Follow> .

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

TheAnswerPage

JANUARY 11, 2022

As a result, state medical marijuana rules and regulations have focused on the demands of the public without putting significant emphasis on the scientific data or the ability of the medical community to support and care for medical marijuana patients.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

APRIL 12, 2019

Being of European descent it is a privilege to be updating Europe on such an exciting topic. I use medical cannabis to treat ankylosing spondylitis and psoriatic arthritis among many other autoimmune conditions, mental health and the effects of chronic inflammation. million medical cannabis patients in Canada.

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

JULY 24, 2019

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Mental conditions like anxiety, depression, and PTSD.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. Edibles won’t produce the same experience, but topicals may be able to help, too. A secondary headache is a symptom of another medical issue.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. The Environment Testing business in North America was impacted by restrictions around sample collection and adverse weather conditions. On 22 April 2021, Mr. Pascal Rakovsky was appointed as Lead Independent Director.

Business 105

Business Research and Development Environment Food 105

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Topical CBD for pain. CBD tinctures or oil drops can also be applied directly onto the skin as a topical or mixed with your own lotion for coverage over a greater area.

CBD 98

CBD Chronic Pain Oil Topical 98

The Cannigma

DECEMBER 1, 2021

the authors compared the safety record of cannabis with that of alcohol. Additionally, those who choose to ingest cannabis by vaping, applying topicals, or eating edibles, can sidestep the harms associated with smoking. Your parents may even find that cannabis could help with conditions that affect them. Types of cannabis.

Research and Development 103

Research and Development Tincture THC Cannabinoids 103

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales.

CBD 144

CBD Seed-To-Sale Food Access 144

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Topical CBD for pain. CBD tinctures or oil drops can also be applied directly onto the skin as a topical or mixed with your own lotion for coverage over a greater area.

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Topical CBD for pain. CBD tinctures or oil drops can also be applied directly onto the skin as a topical or mixed with your own lotion for coverage over a greater area.

CBD 52

CBD Chronic Pain Oil Topical 52

The Cannigma

JULY 9, 2023

The fact that THC binds with important cannabinoid receptors in the brain, and the fact that THC can pass from the mother through the placenta to the developing fetus indeed raises questions about the safety of exposing an unborn baby to THC. A 2022 systematic review and meta-analysis that reviewed data from approximately 5.5

Research and Development 68

Research and Development THC Cannabinoids Topical 68

Cannabis Law Report

AUGUST 6, 2021

1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country. Excise taxes.

Vaping 105

Vaping Research and Development Data Business 105

Greenspoon Marder Cannabis Law Group Blog

JUNE 4, 2019

The hearing was intended to listen, question, and ultimately understand the scientific data, general information, and immediate issues surrounding CBD products that will need to be addressed as FDA considers legal pathways for CBD. Several speakers expressed a deep concern for consumers that use and depend on CBD to treat certain conditions.

CBD 74

CBD Research and Development Safety Topical 74

Cannabis Law Report

JUNE 25, 2021

According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Level of Regulation.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91